Clinical trial
Biological Therapy in Treating Patients With Metastatic Cancer
NCT00004604 · Duke University, Other · Completed
Key facts
| NCT number | NCT00004604 |
|---|---|
| Title | Biological Therapy in Treating Patients With Metastatic Cancer |
| Official title | A Phase I Study of Active Immunotherapy With Carcinoembryonic Antigen RNA-Pulsed, Autologous Human Cultured Dendritic Cells in Patients With Metastatic Malignancies Expressing Carcinoembryonic Antigen |
| Lead sponsor | Duke University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer, Colorectal Cancer, Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Gastric Cancer, Head and Neck Cancer, Liver Cancer, Lung Cancer, Metastatic Cancer, Ovarian Cancer and 2 more |
| Intervention type | Biological |
| Interventions | CEA RNA-pulsed DC cancer vaccine |
| Enrollment | 24 |
| Start date | Feb 1, 1997 |
| Primary completion | Jun 1, 2001 |
| Completion | Jul 1, 2002 |
| First posted | Apr 28, 2004 |
| Last update posted | Feb 22, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: